Literature DB >> 20811532

Hepatocellular carcinoma and the underlying mechanisms.

A A Oyagbemi1, O I Azeez, A B Saba.   

Abstract

The incidence of hepatocellular carcinoma is increasing worldwide as well as the associated risk factors, some of which include exposure to aflatoxin B1, Hepatitis B (HBV) virus and hepatitis C (HCV) virus. Mutation of tumour suppressor gene p53 at codon 249(ser) at exon 7 has been found to contribute significantly to replication of damaged DNA and subsequent tumour progression. The x gene of HBV (HBx) is the most common open reading frame integrated into the host genome in hepatocellular carcinoma and the integrated HBx is frequently mutated in hepatocellular carcinoma. Mutant HBx proteins still retain their ability to bind to p53 thereby attenuating DNA repair and p53-mediated apoptosis.

Entities:  

Keywords:  HBV; HCV; aflatoxin B1; hepatocellular carcinoma; p53

Mesh:

Substances:

Year:  2010        PMID: 20811532      PMCID: PMC2895801     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  47 in total

Review 1.  Translational strategies for cancer prevention in liver.

Authors:  Thomas W Kensler; Geng-Sun Qian; Jian-Guo Chen; John D Groopman
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

Review 2.  Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.

Authors:  P Arbuthnot; A Capovilla; M Kew
Journal:  J Gastroenterol Hepatol       Date:  2000-04       Impact factor: 4.029

3.  Hepatitis B virus and the prevention of primary cancer of the liver.

Authors:  B S Blumberg; W T London
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

4.  Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.

Authors:  M C Stern; D M Umbach; M C Yu; S J London; Z Q Zhang; J A Taylor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

Review 5.  Chromosomal proteins.

Authors:  R H Stellwagen; R D Cole
Journal:  Annu Rev Biochem       Date:  1969       Impact factor: 23.643

Review 6.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients.

Authors:  Peta E Jackson; Shuang-Yuan Kuang; Jin-Bing Wang; Paul T Strickland; Alvaro Muñoz; Thomas W Kensler; Geng-Sun Qian; John D Groopman
Journal:  Carcinogenesis       Date:  2003-07-17       Impact factor: 4.944

8.  Trout testis cells. 3. Acetylation of histones in different cell types from developing trout testis.

Authors:  E P Candido; G H Dixon
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

9.  Modification of histones during spermiogenesis in trout: a molecular mechanism for altering histone binding to DNA.

Authors:  M T Sung; G H Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

10.  A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma.

Authors:  S Hadziyannis; E Tabor; E Kaklamani; A Tzonou; S Stuver; N Tassopoulos; N Mueller; D Trichopoulos
Journal:  Int J Cancer       Date:  1995-03-03       Impact factor: 7.396

View more
  2 in total

Review 1.  How did hepatitis B virus effect the host genome in the last decade?

Authors:  Pinar Ozkal-Baydin
Journal:  World J Hepatol       Date:  2014-12-27

2.  Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta.

Authors:  Jiani Wang; Lihua Xu; Weigen Zeng; Pan Hu; Musheng Zeng; Samuel D Rabkin; Renbin Liu
Journal:  Cancer Cell Int       Date:  2014-09-19       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.